Published in Bioconjug Chem on July 01, 2009
Residue-specific incorporation of non-canonical amino acids into proteins: recent developments and applications. Curr Opin Chem Biol (2010) 1.61
Advances in Bioconjugation. Curr Org Chem (2010) 1.60
Enzymatic labeling of proteins: techniques and approaches. Bioconjug Chem (2013) 1.18
Monitoring protein interactions and dynamics with solvatochromic fluorophores. Trends Biotechnol (2009) 1.10
Clickable bifunctional radiometal chelates for peptide labeling. Chem Commun (Camb) (2010) 1.06
Site-specific protein modification using lipoic acid ligase and bis-aryl hydrazone formation. Chembiochem (2012) 0.96
Assembly of protein building blocks using a short synthetic peptide. Bioconjug Chem (2012) 0.85
Cell-free protein synthesis: the state of the art. Biotechnol Lett (2012) 0.83
Therapeutic applications of an expanded genetic code. Chembiochem (2014) 0.82
Development of quinic acid-conjugated nanoparticles as a drug carrier to solid tumors. Biomacromolecules (2013) 0.81
Tethered spectroscopic probes estimate dynamic distances with subnanometer resolution in voltage-dependent potassium channels. Biophys J (2013) 0.80
Unnatural amino acid incorporation in E. coli: current and future applications in the design of therapeutic proteins. Front Chem (2014) 0.80
Genetic PEGylation. PLoS One (2012) 0.80
Multiple site-selective insertions of noncanonical amino acids into sequence-repetitive polypeptides. Chembiochem (2013) 0.80
Diverse functionalization of Aurora-A kinase at specified surface and buried sites by native chemical modification. PLoS One (2014) 0.79
Engineering protein farnesyltransferase for enzymatic protein labeling applications. Bioconjug Chem (2014) 0.78
Spatially addressable chemoselective C-terminal ligation of an intein fusion protein from a complex mixture to a hydrazine-terminated surface. Langmuir (2010) 0.78
Rapid and selective separation for mixed proteins with thiol functionalized magnetic nanoparticles. Nanoscale Res Lett (2012) 0.77
Simple Protein Modification Using Zwitterionic Polymer to Mitigate the Bioactivity Loss of Conjugated Insulin. Adv Healthc Mater (2017) 0.77
Site-specific conjugation of RAFT polymers to proteins via expressed protein ligation. Chem Commun (Camb) (2013) 0.76
Site-Specific PEGylation of Therapeutic Proteins. Int J Mol Sci (2015) 0.76
Effects of Non-Natural Amino Acid Incorporation into the Enzyme Core Region on Enzyme Structure and Function. Int J Mol Sci (2015) 0.75
Forced Ambiguity of the Leucine Codons for Multiple-Site-Specific Incorporation of a Noncanonical Amino Acid. PLoS One (2016) 0.75
Identification of formaldehyde-induced modifications in proteins: reactions with model peptides. J Biol Chem (2003) 2.60
Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release (2011) 2.37
Sheddable coatings for long-circulating nanoparticles. Pharm Res (2007) 2.15
Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum (2006) 1.98
Theranostic nanomedicine. Acc Chem Res (2011) 1.84
Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res (2010) 1.83
Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials (2009) 1.70
Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J Control Release (2007) 1.64
Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol Pharm (2010) 1.60
Novel bioreducible poly(amido amine)s for highly efficient gene delivery. Bioconjug Chem (2007) 1.56
25th anniversary article: Engineering hydrogels for biofabrication. Adv Mater (2013) 1.54
Artificial viruses: a nanotechnological approach to gene delivery. Nat Rev Drug Discov (2006) 1.52
Directed evolution by in vitro compartmentalization. Nat Methods (2006) 1.45
Hydrogels for protein delivery. Chem Rev (2012) 1.44
Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer. PLoS One (2013) 1.42
Hydrogels as extracellular matrices for skeletal tissue engineering: state-of-the-art and novel application in organ printing. Tissue Eng (2007) 1.42
In situ gelling hydrogels for pharmaceutical and biomedical applications. Int J Pharm (2008) 1.41
Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes. J Control Release (2012) 1.39
The effect of photopolymerization on stem cells embedded in hydrogels. Biomaterials (2008) 1.39
Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines. Nano Lett (2014) 1.37
Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles. Nanomedicine (2011) 1.37
Identification of formaldehyde-induced modifications in proteins: reactions with insulin. Bioconjug Chem (2006) 1.37
Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications. Biomacromolecules (2009) 1.33
Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies. Biomaterials (2007) 1.30
Linear poly(amido amine)s with secondary and tertiary amino groups and variable amounts of disulfide linkages: synthesis and in vitro gene transfer properties. J Control Release (2006) 1.26
Organ printing: the future of bone regeneration? Trends Biotechnol (2011) 1.26
Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev (2009) 1.26
Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. Int J Pharm (2006) 1.25
Synthesis and characterization of hyperbranched polyglycerol hydrogels. Biomaterials (2006) 1.24
Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. Biomaterials (2009) 1.24
The immunogenicity of polyethylene glycol: facts and fiction. Pharm Res (2013) 1.24
Bioreducible poly(amido amine)s with oligoamine side chains: synthesis, characterization, and structural effects on gene delivery. J Control Release (2007) 1.21
In vitro compartmentalization by double emulsions: sorting and gene enrichment by fluorescence activated cell sorting. Anal Biochem (2004) 1.20
Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Biomaterials (2010) 1.17
How to screen non-viral gene delivery systems in vitro? J Control Release (2011) 1.17
A versatile family of degradable non-viral gene carriers based on hyperbranched poly(ester amine)s. J Control Release (2005) 1.16
Pulsed in vitro release and in vivo behavior of exploding microcapsules. J Control Release (2009) 1.15
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release (2005) 1.13
Endosomal escape of polymeric gene delivery complexes is not always enhanced by polymers buffering at low pH. Biomacromolecules (2004) 1.09
The nuclear pore complex: the gateway to successful nonviral gene delivery. Pharm Res (2006) 1.07
Degradable-brushed pHEMA-pDMAEMA synthesized via ATRP and click chemistry for gene delivery. Bioconjug Chem (2007) 1.06
Targeting tumor antigens to dendritic cells using particulate carriers. J Control Release (2012) 1.05
Hydrogels for protein delivery in tissue engineering. J Control Release (2012) 1.04
Self-assembly of recombinant amphiphilic oligopeptides into vesicles. Biomacromolecules (2007) 1.02
Sensitive spectroscopic detection of large and denatured protein aggregates in solution by use of the fluorescent dye Nile red. J Fluoresc (2007) 1.02
Challenges for the effective molecular imprinting of proteins. Biomaterials (2011) 1.02
Shifting paradigms: biopharmaceuticals versus low molecular weight drugs. Int J Pharm (2003) 1.02
Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Langmuir (2009) 1.02
Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff. Biomaterials (2005) 1.01
Synthesis and applications of biomedical and pharmaceutical polymers via click chemistry methodologies. Bioconjug Chem (2009) 1.01
Functional aliphatic polyesters for biomedical and pharmaceutical applications. J Control Release (2011) 1.01
Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. J Control Release (2005) 0.98
Microcapsules ejecting nanosized species into the environment. J Am Chem Soc (2008) 0.98
Polymer side-chain degradation as a tool to control the destabilization of polyplexes. Pharm Res (2004) 0.98
Methacrylamide polymers with hydrolysis-sensitive cationic side groups as degradable gene carriers. Bioconjug Chem (2006) 0.97
Poly(3-guanidinopropyl methacrylate): a novel cationic polymer for gene delivery. Bioconjug Chem (2004) 0.97
Biocompatibility and degradation characteristics of PLGA-based electrospun nanofibrous scaffolds with nanoapatite incorporation. Biomaterials (2012) 0.96
Angiogenic endothelium shows lactadherin-dependent phagocytosis of aged erythrocytes and apoptotic cells. Blood (2008) 0.96
Mobility of model proteins in hydrogels composed of oppositely charged dextran microspheres studied by protein release and fluorescence recovery after photobleaching. J Control Release (2005) 0.95
In vivo biocompatibility and biodegradation of 3D-printed porous scaffolds based on a hydroxyl-functionalized poly(ε-caprolactone). Biomaterials (2012) 0.95
Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain. J Control Release (2010) 0.95
Photopolymerized thermosensitive hydrogels: synthesis, degradation, and cytocompatibility. Biomacromolecules (2008) 0.95
Holmium-loaded poly(L-lactic acid) microspheres: in vitro degradation study. Biomacromolecules (2006) 0.94
A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity. Bioconjug Chem (2003) 0.94
Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres. Pharm Res (2011) 0.94
Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy. Biomaterials (2012) 0.93
Self-gelling hydrogels based on oppositely charged dextran microspheres. Biomaterials (2005) 0.93
Molar-mass characterization of cationic polymers for gene delivery by aqueous size-exclusion chromatography. Pharm Res (2006) 0.92
Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis. Angew Chem Int Ed Engl (2012) 0.91
Optimization of intradermal vaccination by DNA tattooing in human skin. Hum Gene Ther (2009) 0.91
Long-term toxicity of holmium-loaded poly(L-lactic acid) microspheres in rats. Biomaterials (2007) 0.91
In vitro hydrolytic degradation of hydroxyl-functionalized poly(alpha-hydroxy acid)s. Biomacromolecules (2007) 0.91
Stabilization of peptide vesicles by introducing inter-peptide disulfide bonds. Pharm Res (2009) 0.90
Macroscopic hydrogels by self-assembly of oligolactate-grafted dextran microspheres. Biomacromolecules (2007) 0.90
Preparation and characterization of cephalexin loaded PLGA microspheres. Curr Drug Deliv (2009) 0.90
OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. Biochim Biophys Acta (2004) 0.90
Recombinant gelatin hydrogels for the sustained release of proteins. J Control Release (2007) 0.90
Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. Vaccine (2003) 0.90
A comparison between the use of dynamic mechanical analysis and oscillatory shear rheometry for the characterisation of hydrogels. Int J Pharm (2002) 0.90
Identification of peptide ligands for targeting to the blood-brain barrier. Pharm Res (2010) 0.90
Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties. Biomacromolecules (2005) 0.90
Novel poly(amido amine)s with bioreducible disulfide linkages in their diamino-units: structure effects and in vitro gene transfer properties. J Control Release (2008) 0.89
Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes. Vaccine (2003) 0.89
Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration. Biochim Biophys Acta (2006) 0.89
Development of a murine model to evaluate the effect of vernix caseosa on skin barrier recovery. Exp Dermatol (2008) 0.89
Biodegradable dextran hydrogels for protein delivery applications. Expert Rev Med Devices (2007) 0.89
Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels. J Control Release (2007) 0.89
In vitro and in vivo protein delivery from in situ forming poly(ethylene glycol)-poly(lactide) hydrogels. J Control Release (2007) 0.88
Synthesis and characterization of enzymatically biodegradable PEG and peptide-based hydrogels prepared by click chemistry. Biomacromolecules (2010) 0.88
Synthesis and characterization of biodegradable peptide-based polymers prepared by microwave-assisted click chemistry. Biomacromolecules (2008) 0.88
In vivo methods to study uptake of nanoparticles into the brain. Pharm Res (2010) 0.87
SiRNA delivery with functionalized carbon nanotubes. Int J Pharm (2011) 0.87